Biotech Short Candidates | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biotech Short Candidates

An SI Board Since December 2000

Posts	SubjectMarks	Bans
897	95	0

Emcee: tuck	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
47	Shorted it at $47, January 1992. One of only three times I can remember having	scaram(o)uche	-	6/1/2001
46	Congratulations! IMNR has bombed before and has done it again. Your interpretati	Spekulatius	-	6/1/2001
45	Ralf, Covered IMNR this morning for a lot more % gain than you'll ever get	tuck	-	6/1/2001
44	FT had an article about Aranesp a while ago. According to FT's interpretatio	Spekulatius	-	5/30/2001
43	Ralf, Mind expanding on Aranesp's problems? Meanwhile, watching IMNR for d	tuck	-	5/29/2001
42	I indeed feel that AMGN is quite overvalued. P/E is around 50. Aranesp seems to	Spekulatius	-	5/25/2001
41	Disappointing clinical results. Short placebo companies. <b>Is the Placeb	opalapril	-	5/24/2001
40	stefaan, I see resistance on the weekly chart at 18 and up. I have an order to	tuck	-	5/24/2001
39	tuck why dont we buy puts on it ? anyway shorting like i did today was a desast	dalroi	-	5/24/2001
38	A little more info on the GENE analyst: Message 15848652 Cheers, Tuck	tuck	-	5/24/2001
37	Waiting for the volume to dry up on GENE, at which point, it should make an exce	tuck	-	5/24/2001
36	<i>if the runup is due to the PRECLINICAL results</i> That was my f	nigel bates	-	5/17/2001
35	if the runup is due to the PRECLINICAL results then by all means yes short cyto,	dalroi	-	5/16/2001
34	CYTO ? (eom)	nigel bates	-	5/16/2001
33	How about a fresh look at CRA as a short? Their business model, fuzzy at best,	tuck	-	5/16/2001
32	amgen a 1 product ??????????? epogen neupogen and they also have a third one a	dalroi	-	2/13/2001
31	AMGN is overvalued here, easy to understand the company's fundamental with t	200ma	-	2/13/2001
30	wouldn't be sharp shorting this one IMHO sightings.com	long-gone	-	2/10/2001
29	In the absence of earnings, and an alreeady factored in rate cut, the shorts are	cyberman	-	2/7/2001
28	prophet_often & thread, Revisiting some of the biotechs facing lock-up expi	tuck	-	1/24/2001
27	TKTX headed down... and down... and down over the next several weeks. Hard to kn	opalapril	-	1/21/2001
26	Covered IMNX short AH Friday at 33.125 for a four day 13% profit. AMGN news may	prophet_often	-	1/21/2001
25	Here is a better link: quote.bloomberg.com <<<"Immunex has said	prophet_often	-	1/17/2001
24	prophet_often, Thanks for your thoughts. I found the article confusing at firs	tuck	-	1/17/2001
23	Re: IMNX, Enbrel production problems, explains why the chart looked so poor. Tha	prophet_often	-	1/17/2001

Go to reply# or date (mm/dd/yy):